Trevena to present TRV027 Phase 1 clinical data at 16th Annual Heart Failure ... News-Medical.net Trevena, Inc., the leader in the discovery of G-protein coupled receptor (GPCR) biased ligands, today announced that it is presenting a poster featuring Phase 1 clinical data on TRV027 at the 16th Annual Heart Failure Society of America Meeting being ... Trevena Presents Phase 1 Clinical Data for TRV027, a ?-arrestin Biased AT1R ... |
